Literature DB >> 20554088

[Hypothyroidism as the result of drug interaction between ferrous sulfate and levothyroxine].

E Fiaux1, K Kadri, C Levasseur, C Le Guillou, P Chassagne.   

Abstract

We report a case of drug-drug interaction between ferrous sulfate and l-thyroxin. A 95-year-old woman treated successfully with l-thyroxin for many years received ferrous sulfate for anemia. This association led rapidly to recurrence of hypothyroidism with elevated serum than TSH level which completely resolved after withdrawal of iron therapy. Interaction was confirmed after both drugs were daily administrated separately without recurrence of hypothyroidism.
Copyright © 2010 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554088     DOI: 10.1016/j.revmed.2009.09.038

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  4 in total

1.  Using body mass index to predict optimal thyroid dosing after thyroidectomy.

Authors:  Kristin A Ojomo; David F Schneider; Alexandra E Reiher; Ngan Lai; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  J Am Coll Surg       Date:  2013-01-11       Impact factor: 6.113

Review 2.  A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.

Authors:  Philippe Colucci; Corinne Seng Yue; Murray Ducharme; Salvatore Benvenga
Journal:  Eur Endocrinol       Date:  2013-03-15

Review 3.  An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

Authors:  Stefano Stagi; Giovanna Municchi; Marta Ferrari; Malgorzata Gabriela Wasniewska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 4.  Levothyroxine Interactions with Food and Dietary Supplements-A Systematic Review.

Authors:  Agnieszka Wiesner; Danuta Gajewska; Paweł Paśko
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.